50
Participants
Start Date
July 27, 2022
Primary Completion Date
March 31, 2026
Study Completion Date
July 20, 2043
HER2 Specific CAR T Cell
HER2 CAR (Chimeric Antigen Receptor) T cells are T cells that have been genetically engineered to target the protein HER2 for the treatment of cancer.
Memorial Sloan Kettering Cancer Center, New York
Pittsburgh Children's Hospital of UPMC, Pittsburgh
Children's National Medical Center, Washington D.C.
Children's Healthcare of Atlanta, Atlanta
University of Florida, Gainesville
Nationwide Children's Hospital, Columbus
Cincinnati Children's Hospital Medical Center, Cincinnati
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Texas Children's Cancer Center, Houston
Children's Hospital Colorado, Aurora
Children's Hospital Los Angeles, Los Angeles
Dana Farber Cancer Institute, Boston
The Hospital for Sick Children, Toronto
Texas Children's Cancer Center
OTHER
Baylor College of Medicine
OTHER
National Cancer Institute (NCI)
NIH
American Lebanese Syrian Associated Charities
OTHER
Pediatric Brain Tumor Consortium
NETWORK